Objective: To evaluate changes in self-reported depression after treatment of fecal incontinence (FI) with sacral neuromodulation.
Materials And Methods: This is a subanalysis of data collected from March 2016 to October 2017 for an Institutional Review Board-approved retrospective cohort study. Demographic information, medical history, psychiatric comorbidities, and the Patient-Reported Outcomes Measurement Information System item bank t-scores were extracted from the electronic medical record.